protein-bound paclitaxel
Term · Oncology and biomedicine · MLC-T-ONC-007009
A form of the anticancer drug paclitaxel that is used alone or with other drugs to treat certain types of breast cancer, non-small cell lung cancer, and pancreatic cancer. Protein-bound paclitaxel may have fewer side effects and work better than other forms of paclitaxel. It is also being studied in the treatment of other types of cancer. Protein-bound paclitaxel stops cancer cells from growing and dividing and may kill them. It is a type of taxane. Also called ABI-007, Abraxane, nanoparticle paclitaxel, and paclitaxel albumin-stabilized nanoparticle formulation.
| Identifier | MLC-T-ONC-007009 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | ABI-007; Abraxane; nanoparticle paclitaxel; paclitaxel albumin-stabilized nanoparticle formulation |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-007009",
"term": "protein-bound paclitaxel",
"field": "Oncology and biomedicine",
"definition": "A form of the anticancer drug paclitaxel that is used alone or with other drugs to treat certain types of breast cancer, non-small cell lung cancer, and pancreatic cancer. Protein-bound paclitaxel may have fewer side effects and work better than other forms of paclitaxel. It is also being studied in the treatment of other types of cancer. Protein-bound paclitaxel stops cancer cells from growing and dividing and may kill them. It is a type of taxane. Also called ABI-007, Abraxane, nanoparticle paclitaxel, and paclitaxel albumin-stabilized nanoparticle formulation.",
"synonyms": [
"ABI-007",
"Abraxane",
"nanoparticle paclitaxel",
"paclitaxel albumin-stabilized nanoparticle formulation"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/protein-bound-paclitaxel/"
}
Record 13,763 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.